Trial
NCT06030648
MT2022-01: MSCs for ALD
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Cerebral Adrenoleukodystrophy
Intervention
Mesenchymal stem cells (IV-MSC)
Why stopped
Awaiting supplies
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-18